Huntsman anticipates early-2027 close of Olin merger while targeting $300M synergies plus $100M from expiring chlorine contracts (NYSE:HUN)
Huntsman Corporation (HUN) expects to complete its merger with Olin by early 2027, targeting $300M in synergies and an additional $100M from expiring chlorine contracts. The company anticipates a $100M improvement in 2026 EBITDA compared to 2025, according to CEO Peter Huntsman.
How this was made
The 30-second read
Why it matters
The disclosed EBITDA improvement reinforces confidence in the merger's value creation.
Market read
Guidance lift is a fresh, material data point for HUN, offering a short‑term trading edge.
What to watch
Potential integration risks from the pending Olin merger could offset short‑term gains.
Background
Huntsman Corp. is progressing toward its planned merger with Olin Corp., targeting $300M synergies.
Ticker impact
Management announced >$100M EBITDA improvement for 2026 versus 2025 during the Q3 earnings call.
upward pressure as investors price in higher earnings outlook
EBITDA improvement of over $100M is material for a mid‑cap chemical company and signals operational success.
Market effects
Improved earnings may boost sentiment in the specialty chemicals sector.
North American chemical stocks could see modest gains.
Limited to investors tracking mid‑cap industrial firms.
Counterpoint
If cost inflation accelerates, the EBITDA boost may be temporary.
Key entities
- companyHuntsman Corporation
Specialty chemicals producer (NYSE:HUN).
- executivePeter Huntsman
Chairman, President & CEO of Huntsman.



